The NIH Library is pleased to offer trial access to NEJM Evidence through June 30, 2022. NEJM Evidence is a new clinical research journal that presents innovative research and ideas in clinical trial design and clinical decision-making. Each monthly issue includes original research, reviews, and case studies. Additional content includes perspectives from patients and trialists, short explanatory videos, and other article types to support learning and challenge thinking around how trials are designed, conducted, and analyzed.
NEJM Evidence help readers understand how trials are assembled, run, and analyzed. This new journal brings a fresh approach modeled on the morning case-based rounds of medical training programs. NEJM Evidence also seeks to diversify its voices through the selection of its authors, reviewers, and editorial board.
Let Us Know What You Think
Try NEJM Evidence and let us know what you think. During the trial access period (now through June 30), send feedback through the Library’s Suggest a Resource form—be sure to include the name of the resource “NEJM Evidence” in the “RECOMMENDED TITLE OR NAME OF PRODUCT” field.
NEJM Evidence is a publication of NEJM Group, which also publishes the New England Journal of Medicine (NEJM).
For questions or more information, contact Lisa Scanlon, firstname.lastname@example.org.